Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02223520 · ClinicalTrials.gov registry record · NA
Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
A NA study of Staph Aureus Colonization and Staph Aureus Infection, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 307
- Enrollment target
- 2
- Study locations
NCT02223520 is a NA study of Staph Aureus Colonization and Staph Aureus Infection that has completed, run by Johns Hopkins University. The registered enrollment target is 307 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT02223520, a NA study of Staph Aureus Colonization and Staph Aureus Infection, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 307 participants
- Enrollment target
- 2
- Study locations
Study Summary
This trial will test the hypothesis that treating parents of neonates requiring NICU care with intranasal mupirocin and topical chlorhexidine bathing will reduce the spread of S. aureus from parents to neonates.
Conditions Studied
Interventions
- DRUG Mupirocin and Chlorhexidine
- DRUG Placebo ointment and placebo cloths
Study Locations (2)
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02223520
The ClinicalTrials.gov registry entry for NCT02223520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Staph Aureus Colonization appearing as the primary indexed condition, and to 2 interventions - of which Mupirocin and Chlorhexidine is the first listed.
NCT02223520 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02223520 about?
NCT02223520 is a clinical study titled "Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial". This trial will test the hypothesis that treating parents of neonates requiring NICU care with intranasal mupirocin and topical chlorhexidine bathing will reduce the spread of S. aureus from parents to neonates.
What is the current status of trial NCT02223520?
This trial is currently completed. It is a NA study. The enrollment target is 307 participants. The study started on 2014-11. Estimated completion is 2019-10-31.
What conditions does trial NCT02223520 study?
This clinical trial studies the following conditions: Staph Aureus Colonization, Staph Aureus Infection.
What interventions are being tested in trial NCT02223520?
The interventions under investigation include: Mupirocin and Chlorhexidine (DRUG), Placebo ointment and placebo cloths (DRUG).
Who is sponsoring clinical trial NCT02223520?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02223520 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.